Signal2026-06-17
ClinicalTrials.gov

[PHASE3] Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine

Part of

COVID-19 Epidemiology And Vaccine Studies

Open primary sourceSee the whole picture